242 related articles for article (PubMed ID: 32106239)
41. Assessing myeloma bone disease with whole-body diffusion-weighted imaging: comparison with x-ray skeletal survey by region and relationship with laboratory estimates of disease burden.
Giles SL; deSouza NM; Collins DJ; Morgan VA; West S; Davies FE; Morgan GJ; Messiou C
Clin Radiol; 2015 Jun; 70(6):614-21. PubMed ID: 25799364
[TBL] [Abstract][Full Text] [Related]
42. Multiparametric analysis of bone marrow in cancer patients using simultaneous PET/MR imaging: Correlation of fat fraction, diffusivity, metabolic activity, and anthropometric data.
Schraml C; Schmid M; Gatidis S; Schmidt H; la Fougère C; Nikolaou K; Schwenzer NF
J Magn Reson Imaging; 2015 Oct; 42(4):1048-56. PubMed ID: 25683203
[TBL] [Abstract][Full Text] [Related]
43. Intravoxel incoherent motion diffusion-weighted imaging of bone marrow in patients with acute myeloid leukemia: a pilot study of prognostic value.
Niu J; Li W; Wang H; Wu W; Gong T; Huang N; Wang J; Qi Y
J Magn Reson Imaging; 2017 Aug; 46(2):476-482. PubMed ID: 28211619
[TBL] [Abstract][Full Text] [Related]
44. Measurement of fat content in vertebral marrow using a modified dixon sequence to differentiate benign from malignant processes.
Yoo HJ; Hong SH; Kim DH; Choi JY; Chae HD; Jeong BM; Ahn JM; Kang HS
J Magn Reson Imaging; 2017 May; 45(5):1534-1544. PubMed ID: 27690264
[TBL] [Abstract][Full Text] [Related]
45. Longitudinal monitoring of apparent diffusion coefficient (ADC) in myeloma patients with lower M-gradient levels undergoing systemic treatment and whole-body MRI monitoring.
Perl RM; Gronbach F; Fritz J; Horger MS; Hepp T
Eur J Radiol; 2020 Nov; 132():109306. PubMed ID: 33038578
[TBL] [Abstract][Full Text] [Related]
46. Tumor load in patients with multiple myeloma: β2-microglobulin levels versus whole-body MRI.
D'Anastasi M; Notohamiprodjo M; Schmidt GP; Dürr HR; Reiser MF; Baur-Melnyk A
AJR Am J Roentgenol; 2014 Oct; 203(4):854-62. PubMed ID: 25247952
[TBL] [Abstract][Full Text] [Related]
47. Bone metastases from prostate, breast and multiple myeloma: differences in lesion conspicuity at short-tau inversion recovery and diffusion-weighted MRI.
Pearce T; Philip S; Brown J; Koh DM; Burn PR
Br J Radiol; 2012 Aug; 85(1016):1102-6. PubMed ID: 22457319
[TBL] [Abstract][Full Text] [Related]
48. Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
Balbo-Mussetto A; Cirillo S; Bruna R; Gueli A; Saviolo C; Petracchini M; Fornari A; Lario CV; Gottardi D; De Crescenzo A; Tarella C
Clin Radiol; 2016 Mar; 71(3):271-9. PubMed ID: 26749081
[TBL] [Abstract][Full Text] [Related]
49. Repeatability and reproducibility of apparent diffusion coefficient and fat fraction measurement of focal myeloma lesions on whole body magnetic resonance imaging.
Barwick T; Orton M; Koh DM; Kaiser M; Rockall A; Tunariu N; Blackledge M; Messiou C
Br J Radiol; 2021 Apr; 94(1120):20200682. PubMed ID: 33733812
[TBL] [Abstract][Full Text] [Related]
50. Long-term results in multiple myeloma after high-dose melphalan and autologous transplantation according to response categories in the era of old drugs.
Martino M; Postorino M; Gallo GA; Messina G; Neri S; Piro E; Gentile M; Moscato T; Monteleone R; Fedele R; Mazzone C; Console G; Penna G; Alati C; Vincelli ID; Irrera G; Musolino C; Ronco F; Molica S; Morabito F
Clin Lymphoma Myeloma Leuk; 2014 Apr; 14(2):148-54. PubMed ID: 24417912
[TBL] [Abstract][Full Text] [Related]
51. Quantification of tumor burden in multiple myeloma by atlas-based semi-automatic segmentation of WB-DWI.
Almeida SD; Santinha J; Oliveira FPM; Ip J; Lisitskaya M; Lourenço J; Uysal A; Matos C; João C; Papanikolaou N
Cancer Imaging; 2020 Jan; 20(1):6. PubMed ID: 31931880
[TBL] [Abstract][Full Text] [Related]
52. Signal characteristics of focal bone marrow lesions in patients with multiple myeloma using whole body T1w-TSE, T2w-STIR and diffusion-weighted imaging with background suppression.
Sommer G; Klarhöfer M; Lenz C; Scheffler K; Bongartz G; Winter L
Eur Radiol; 2011 Apr; 21(4):857-62. PubMed ID: 20853109
[TBL] [Abstract][Full Text] [Related]
53. [Preliminary report of fludarabine, mitoxantrone and dexamethasone in treating refractory or relapsed multiple myeloma].
Luo SK; Li J; Hong WD; Zhao Y; Tong XZ
Ai Zheng; 2005 Dec; 24(12):1518-21. PubMed ID: 16351805
[TBL] [Abstract][Full Text] [Related]
54. The quantitative parameters based on marrow metabolism derived from synthetic MRI: A pilot study of prognostic value in participants with newly diagnosed multiple myeloma.
Cui S; Guo Y; Niu W; Li J; Bian W; Wu W; Zhang W; Zheng Q; Wang J; Niu J
Cancer Med; 2024 Apr; 13(7):e7109. PubMed ID: 38553942
[TBL] [Abstract][Full Text] [Related]
55. Bone marrow fat fraction assessment in regard to physical activity: KORA FF4-3-T MR imaging in a population-based cohort.
Bertheau RC; Lorbeer R; Nattenmüller J; Wintermeyer E; Machann J; Linkohr B; Peters A; Bamberg F; Schlett CL
Eur Radiol; 2020 Jun; 30(6):3417-3428. PubMed ID: 32086579
[TBL] [Abstract][Full Text] [Related]
56. Application value of diffusion weighted whole body imaging with background body signal suppression in monitoring the response to treatment of bone marrow involvement in lymphoma.
Sun M; Cheng J; Zhang Y; Wang F; Meng Y; Fu X
J Magn Reson Imaging; 2016 Dec; 44(6):1522-1529. PubMed ID: 27160047
[TBL] [Abstract][Full Text] [Related]
57. Whole body MRI with qualitative and quantitative analysis of DWI for assessment of bone marrow involvement in lymphoma.
Balbo-Mussetto A; Saviolo C; Fornari A; Gottardi D; Petracchini M; Macera A; Lario CV; Gallo T; Tarella C; Cirillo S
Radiol Med; 2017 Aug; 122(8):623-632. PubMed ID: 28421406
[TBL] [Abstract][Full Text] [Related]
58. Mid-term response assessment in multiple myeloma using a texture analysis approach on dual energy-CT-derived bone marrow images - A proof of principle study.
Reinert CP; Krieg EM; Bösmüller H; Horger M
Eur J Radiol; 2020 Oct; 131():109214. PubMed ID: 32835853
[TBL] [Abstract][Full Text] [Related]
59. Whole body MRI in multiple myeloma: Optimising image acquisition and read times.
Singh S; Pilavachi E; Dudek A; Bray TJP; Latifoltojar A; Rajesparan K; Punwani S; Hall-Craggs MA
PLoS One; 2020; 15(1):e0228424. PubMed ID: 31999774
[TBL] [Abstract][Full Text] [Related]
60. Whole-body diffusion-weighted MRI: a new gold standard for assessing disease burden in patients with multiple myeloma?
Pawlyn C; Fowkes L; Otero S; Jones JR; Boyd KD; Davies FE; Morgan GJ; Collins DJ; Sharma B; Riddell A; Kaiser MF; Messiou C
Leukemia; 2016 Jun; 30(6):1446-8. PubMed ID: 26648535
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
